Therefore, counteracting H3K36me2 methylation of the promoter of metabolic regulators targeted by Kdm8 could be investigated as a strategy to maintain energy homeostasis and prevent the initiation of cardiac deterioration toward heart failure. The gene discussed is KDM8; the disease is heart failure.